Two-year follow-up of early- and conventionally-placed two-stage implants supporting fixed prostheses.
The objective of this study was to compare the biologic and prosthetic outcomes of early- and conventionally-placed implants supporting fixed prostheses. Using inclusion/exclusion criteria, early- and conventionally-placed implant patient groups, rehabilitated with Branemark System implants supporting fixed prostheses for 2 years, were selected from the patient archives. Kaplan-Meier survival estimates, time-dependent marginal bone loss, Plaque Index, peri-implant infection, Bleeding Index scores, and prosthetic complications data of the groups were compared. A total of 212 implants were placed in early-placed (n=42, 101 implants) and conventionally-placed (n=45, 111 implants) patient groups and 5 implants failed during the 2-year follow-up. The 1- and 2-year Kaplan-Meier survival probabilities of early-placed (0.98) and conventionally-placed (0.973) groups were comparable (P=.735). The 6-month to 2-year marginal bone loss in the conventionally-placed group was higher than in the early-placed group (P<.05). There were differences between groups on soft tissue scores between the 2 years of function (P<.05). The frequency of prosthetic complications was very low and comparable in both groups (P=.476). Early- and conventionally-placed implants supporting fixed prostheses showed comparable clinical outcomes during the 2-year follow-up, although the marginal bone loss was higher in the latter group.